Published in Obesity and Diabetes Week, May 25th, 2009
"First published December 16, 2008; doi: 10.1152/ajpendo.90526.2008.-Fenofibrate is a peroxisome proliferator-activated receptor-alpha (PPAR alpha) activator that has been clinically used to treat dyslipidemia and insulin resistance. To better understand the molecular mechanisms underlying fenofibrate action, we investigated whether fenofibrate affects serum levels of retinol-binding protein-4 (RBP4),...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.